###begin article-title 0
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
Anaphylactic shock depends on endothelial Gq/G11
###end article-title 0
###begin p 1
###xml 309 310 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 312 314 312 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 317 319 317 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 321 323 321 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 330 331 330 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 552 553 552 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 555 557 555 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 564 566 564 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 568 570 568 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 684 685 684 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 687 689 687 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1045 1046 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1053 1055 1045 1047 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1105 1106 1093 1094 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1113 1115 1097 1099 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1147 1149 1127 1129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1156 1158 1132 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1289 1290 1265 1266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1292 1294 1268 1270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 1017 1021 <span type="species:ncbi:10090">mice</span>
###xml 1068 1072 <span type="species:ncbi:10090">Mice</span>
Anaphylactic shock is a severe allergic reaction involving multiple organs including the bronchial and cardiovascular system. Most anaphylactic mediators, like platelet-activating factor (PAF), histamine, and others, act through G protein-coupled receptors, which are linked to the heterotrimeric G proteins Gq/G11, G12/G13, and Gi. The role of downstream signaling pathways activated by anaphylactic mediators in defined organs during anaphylactic reactions is largely unknown. Using genetic mouse models that allow for the conditional abrogation of Gq/G11- and G12/G13-mediated signaling pathways by inducible Cre/loxP-mediated mutagenesis in endothelial cells (ECs), we show that Gq/G11-mediated signaling in ECs is required for the opening of the endothelial barrier and the stimulation of nitric oxide formation by various inflammatory mediators as well as by local anaphylaxis. The systemic effects of anaphylactic mediators like histamine and PAF, but not of bacterial lipopolysaccharide (LPS), are blunted in mice with endothelial Galphaq/Galpha11 deficiency. Mice with endothelium-specific Galphaq/Galpha11 deficiency, but not with Galpha12/Galpha13 deficiency, are protected against the fatal consequences of passive and active systemic anaphylaxis. This identifies endothelial Gq/G11-mediated signaling as a critical mediator of fatal systemic anaphylaxis and, hence, as a potential new target to prevent or treat anaphylactic reactions.
###end p 1
###begin p 2
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
Anaphylaxis is a serious allergic reaction with a rapid onset and potentially fatal outcome. It can be induced by insect venoms, food, drugs, latex, and other allergens and may affect as much as 1-15% of the population with an increasing prevalence (1-4). Anaphylaxis is characterized by severe hypotension, vascular leakage, cardiac arrhythmia, hypothermia, and bronchial constriction as well as gastrointestinal and skin symptoms. In particular, cardiovascular and pulmonary dysfunction often lead to death.
###end p 2
###begin p 3
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 760 761 760 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 792 793 792 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 1017 1018 1017 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 1159 1160 1159 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 1214 1215 1214 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1221 1223 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 1242 1243 1242 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 1261 1263 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 1303 1304 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 1306 1308 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
Most anaphylactic reactions are caused by IgE-mediated hypersensitivity reactions resulting from cross-linking of allergen-specific IgE molecules bound to the IgE receptor on tissue mast cells and basophils. However, an alternative mechanism involving IgG and macrophages has also been described (5). The allergen-induced activation of mast cells results in the formation and release of multiple mediators that are responsible for the acute and potentially life-threatening symptoms of anaphylactic reactions (6). These mediators include preformed substances like histamine or the proteases tryptase and chymase, which are released upon mast cell activation, and lipid mediators like platelet-activating factor (PAF), cysteinyl leukotrienes, or prostaglandin D2, which are newly synthesized (7). In the context of anaphylactic reactions, these mediators have been shown to act on multiple organs. PAF, histamine, and tryptase activate endothelial cells (ECs) to induce vasodilatation and increased capillary leakage (8-12). PAF, especially, can activate leukocytes (13, 14), and most anaphylactic mediators induce the contraction of bronchial smooth muscles (9, 15, 16). Other organs and cells, such as the heart (9, 10, 17), nervous system (9, 18), platelets (10, 19), or vascular smooth muscle cells (9, 16), are also directly affected by anaphylactic mediators.
###end p 3
###begin p 4
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 161 163 161 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 170 172 170 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 174 176 174 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 221 223 221 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 360 362 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 433 435 430 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 437 439 434 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 526 527 523 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 737 739 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 740 742 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
Most of the anaphylactic mediators exert their effects through G protein-coupled receptors (GPCRs), which are linked to heterotrimeric G proteins of the Gi, Gq/G11, and G12/G13 families (8, 12, 20-24). The G proteins Gq/G11 couple receptors to beta isoforms of phospholipase C resulting in inositol-1,4,5-trisphosphate-mediated mobilization of intracellular Ca2+ and diacylglycerol-dependent activation of protein kinase C, whereas G12/G13 couple receptors to the activation of the Rho/Rho kinase-mediated signaling pathway. Gi-type G proteins couple receptors in an inhibitory fashion to adenylyl cyclase and, in addition, serve as the major source of G protein betagamma complexes which can regulate a variety of channels and enzymes (25-28).
###end p 4
###begin p 5
###xml 568 569 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 571 573 567 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 615 617 611 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 619 621 615 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 794 795 790 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 797 799 793 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 956 957 952 953 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 959 961 955 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 814 818 <span type="species:ncbi:10090">mice</span>
Many mediators of the effector phase of anaphylactic reactions have been described, and their cellular effects in the heart and the vascular, bronchial, and immune systems have been analyzed. However, the downstream signaling pathways mediating the effects in defined organs during anaphylaxis remain largely unclear. In this study, we analyzed the role of defined endothelial G protein-mediated signaling pathways in anaphylaxis. By conditional mutagenesis of genes encoding particular G protein alpha subunits, we show that the endothelium-specific ablation of the Gq/G11-mediated signaling pathway, but not the G12/G13-mediated signaling pathway, blocks nitric oxide (NO) formation and loss of the endothelial barrier function in response to various vasoactive stimuli. Lack of endothelial Gq/G11 also protects mice from the deleterious consequences of PAF injection as well as of active and passive systemic anaphylaxis. Our data identify endothelial Gq/G11-mediated signaling as an essential mediator of systemic anaphylaxis.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 93 95 93 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
Endothelial effects of inflammatory mediators acting via GPCRs are mediated primarily by Gq/G11
###end title 7
###begin p 8
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 27 29 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 36 38 36 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 40 42 40 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 160 161 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 163 165 159 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 170 172 166 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 174 176 170 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 250 251 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 253 257 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnaq</italic>
###xml 269 271 257 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 273 278 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna13</italic>
###xml 345 347 329 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 358 360 338 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 384 386 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 388 390 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 409 410 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 417 419 389 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 429 431 397 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 438 440 402 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 509 513 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnaq</italic>
###xml 513 522 477 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 523 528 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna11</italic>
###xml 528 531 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 537 542 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna12</italic>
###xml 542 545 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 546 551 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna13</italic>
###xml 551 560 515 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 648 656 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 691 695 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnaq</italic>
###xml 695 704 659 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 705 710 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna11</italic>
###xml 710 713 674 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 717 722 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna12</italic>
###xml 722 725 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 726 731 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna13</italic>
###xml 731 740 695 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 763 764 723 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 771 773 727 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 784 786 736 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 793 795 741 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
To analyze the role of Gq/G11- and G12/G13-mediated signaling in endothelial responses to vasoactive mediators, we generated ECs lacking the alpha subunits of Gq/G11 or G12/G13. We have previously generated floxed alleles of the genes encoding Galphaq (Gnaq) and Galpha13 (Gna13) which allow the conditional inactivation of these genes in Galpha11- or Galpha12-deficient backgrounds (29, 30). To induce Galphaq/Galpha11 or Galpha12/Galpha13 double deficiency, we prepared pulmonary microvascular ECs from WT, Gnaqflox/flox;Gna11-/-, and Gna12-/-;Gna13flox/flox mice and infected them with an adenovirus transducing the recombinase Cre. As shown in Fig. 1 A, expression of Cre recombinase in Gnaqflox/flox;Gna11-/- or Gna12-/-;Gna13flox/flox ECs resulted in Galphaq/Galpha11 and Galpha12/Galpha13 deficiency, respectively.
###end p 8
###begin p 9
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 16 18 16 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 24 26 24 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 28 30 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 0 107 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The role of G<sub>q</sub>/G<sub>11</sub> and G<sub>12</sub>/G<sub>13</sub> in the regulation of NO production and MLC phosphorylation in pulmonary ECs.</bold>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnaq</italic>
###xml 159 168 159 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna11</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 192 197 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna12</italic>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna13</italic>
###xml 206 215 206 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 355 356 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 363 365 355 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 373 375 361 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 584 585 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 592 594 568 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 625 627 597 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 634 636 602 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 994 995 956 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1002 1004 960 962 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1027 1029 981 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1036 1038 986 988 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1307 1308 1253 1254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1351 1352 1293 1294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1761 1762 1697 1698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1769 1771 1701 1703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1803 1805 1731 1733 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1812 1814 1736 1738 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
The role of Gq/G11 and G12/G13 in the regulation of NO production and MLC phosphorylation in pulmonary ECs. (A) Lysates of pulmonary ECs prepared from WT, Gnaqflox/flox;Gna11-/- (q/11-KO), or Gna12-/-;Gna13flox/flox (12/13-KO) mice were infected with Cre-transducing adenovirus and were analyzed by Western blotting with antibodies directed against Galphaq/Galpha11, Galpha13, or alpha-tubulin. Arrowheads indicate the position of the 43-kD marker protein. The presented data are representative of at least five experiments performed with samples from different animals. (B) WT Galphaq/Galpha11-deficient (q/11-KO) and Galpha12/Galpha13-deficient (12/13-KO) ECs were incubated without and with 1 U/ml thrombin (thromb.), 100 nM PAF, or 100 nM ionomycin (ionom.), and NO bioavailability was assessed in a transfer bioassay by determining cGMP production in detector RFL6 fibroblasts by radioimmunoassay. Shown are the results of three separate experiments (mean values +/- SEM). (C-E) WT, Galphaq/Galpha11- (q/11-KO), and Galpha12/Galpha13-deficient (12/13-KO) ECs were incubated in the absence or presence of 1 U/ml thrombin for 1, 3, or 10 min, and the amount of phosphorylated MLC (pMLC) was determined using a phosphorylation site-specific antibody (see Materials and methods). Where indicated (Ad-Galphaq +), cells had been transfected with Galphaq using an adenoviral transfection system. Shown are representative Western blots of cell lysates using the indicated antibodies (C and D) and the results of the densitometric evaluation of three independently performed experiments (E). Shown are mean values +/- SEM. Arrowheads indicate the position of the 25- or 43-kD (D, bottom) marker proteins. (F) Effect of 1 U/ml thrombin on RhoA activity in WT, Galphaq/Galpha11-deficient (q/11-KO), and Galpha12/Galpha13-deficient lung ECs (12/13-KO). Data are from three independently performed experiments (mean values +/- SD).
###end p 9
###begin p 10
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 33 35 33 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 42 44 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 367 368 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 375 377 367 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 398 400 386 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 407 409 391 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 482 490 466 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 603 605 583 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 612 614 588 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 673 674 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 681 683 649 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 891 892 855 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 899 901 859 861 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 911 913 867 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 920 922 872 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 963 964 915 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 966 968 918 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 979 981 931 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 983 985 935 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
We then analyzed the role of Gq/G11- and G12/G13-mediated signaling in the regulation of endothelial NO formation by known endothelial stimuli acting via GPCRs. To determine NO-dependent activation of guanylyl cyclase, we performed a transfer bioassay in which (cyclic guanosine monophosphate) cGMP levels were determined in RFL6 fibroblasts incubated with WT, Galphaq/Galpha11-deficient, or Galpha12/Galpha13-deficient lung ECs treated without or with thrombin, PAF, or ionomycin (Fig. 1 B). Although thrombin and PAF induced a significant increase in cGMP levels in cocultures containing WT and Galpha12/Galpha13-deficient ECs, the effects in cocultures containing Galphaq/Galpha11-deficient ECs were strongly reduced. None of the stimuli induced guanylyl cyclase activation when added to RFL6 fibroblasts or ECs alone (unpublished data). The effect of ionomycin was not affected by Galphaq/Galpha11 or Galpha12/Galpha13 deficiency in ECs. This indicates that Gq/G11, but not G12/G13, are critically involved in thrombin- and PAF-induced NO-dependent stimulation of guanylyl cyclase activity.
###end p 10
###begin p 11
###xml 193 194 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 201 203 193 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 225 227 213 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 234 236 218 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 264 280 248 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 (C and E)</xref>
###xml 457 458 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 465 467 429 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 529 530 489 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 537 539 493 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 616 617 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 619 627 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 644 646 592 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 653 655 597 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 873 874 813 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 881 883 817 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1031 1033 963 965 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1040 1042 968 970 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1044 1052 972 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 F</xref>
Because the phosphorylation state of the myosin light chain (MLC) is a critical determinant of endothelial contractility, we analyzed the effect of thrombin on MLC phosphorylation in WT, Galphaq/Galpha11-deficient, and Galpha12/Galpha13-deficient ECs. As shown in Fig. 1 (C and E), thrombin induced a rapid increase in MLC phosphorylation that was maximal after approximately3 min, whereas thrombin had no effect on MLC phosphorylation in ECs lacking Galphaq/Galpha11. The defect of thrombin-induced MLC phosphorylation in Galphaq/Galpha11-deficient cells could be rescued by adenovirus-mediated expression of Galphaq (Fig. 1 D). Lack of Galpha12/Galpha13 did not completely block thrombin-induced MLC phosphorylation but led to a reduced and more transient response to thrombin. Interestingly, the abrogation of thrombin-induced MLC phosphorylation in cells lacking Galphaq/Galpha11 was not accompanied by any defect in thrombin-induced RhoA activation, whereas thrombin-induced RhoA activation was abrogated in ECs lacking Galpha12/Galpha13 (Fig. 1 F).
###end p 11
###begin title 12
###xml 42 43 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 50 52 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 63 65 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 72 74 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Generation of mice with EC-specific Galphaq/Galpha11 and Galpha12/Galpha13 deficiency
###end title 12
###begin p 13
###xml 45 46 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 53 55 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 66 68 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 75 77 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 281 284 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 286 288 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 291 293 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 320 324 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tie2</italic>
###xml 425 433 409 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tie2-Cre</italic>
###xml 435 437 419 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 519 521 503 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gt</italic>
###xml 522 526 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA</italic>
###xml 527 532 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">26Sor</italic>
###xml 558 566 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 797 805 781 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 826 827 806 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 834 836 810 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 847 849 819 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 856 858 824 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 887 891 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tie2</italic>
###xml 892 895 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 897 899 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 900 904 868 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnaq</italic>
###xml 904 913 872 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 914 919 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna11</italic>
###xml 919 922 887 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 933 934 897 898 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 941 943 901 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 952 956 912 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tie2</italic>
###xml 957 960 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 962 964 922 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 965 970 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna12</italic>
###xml 970 973 930 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 974 979 934 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna13</italic>
###xml 979 988 939 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 999 1001 955 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1008 1010 960 962 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1110 1118 1062 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1247 1248 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1255 1257 1199 1201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1287 1288 1227 1228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1295 1297 1231 1233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
###xml 546 551 <span type="species:ncbi:10090">mouse</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
###xml 1097 1102 <span type="species:ncbi:10090">mouse</span>
###xml 1261 1265 <span type="species:ncbi:10090">mice</span>
For in vivo experiments, we restricted Galphaq/Galpha11 and Galpha12/Galpha13 double deficiency to ECs by using a bacterial artificial chromosome (BAC) transgenic mouse line that expresses a fusion protein of the Cre recombinase with the modified estrogen receptor binding domain (CreERT2) (31) under the control of the tie2 promoter (see Materials and methods). The inducible endothelium-specific Cre transgenic mouse line (tie2-CreERT2) did not show any Cre activity in the absence of tamoxifen when crossed with the Gt(ROSA)26Sor Cre reporter mouse line (Fig. 2 A). However, after treatment of animals with tamoxifen, ECs showed Cre-mediated recombination, indicating that Cre had been activated with high efficacy. Cre-mediated recombination was exclusively observed in ECs of various organs (Fig. 2 A). The lack of Galphaq/Galpha11 and Galpha12/Galpha13 in ECs of tamoxifen-treated tie2-CreERT2;Gnaqflox/flox;Gna11-/- (EC-Galphaq/Galpha11-KO) and tie2-CreERT2;Gna12-/-;Gna13flox/flox (EC-Galpha12/Galpha13-KO) mice was verified by Western blotting of pulmonary EC lysates from the respective mouse lines (Fig. 2 B). Western blot analysis of platelets, leukocytes, and vascular smooth muscle cells showed no difference between WT and EC-Galphaq/Galpha11-KO mice with regard to Galphaq/Galpha11 expression (Fig. S1, available at ).
###end p 13
###begin p 14
###xml 42 43 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 50 52 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 63 65 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 72 74 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 0 86 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Generation of mice with EC-specific G&#945;<sub>q</sub>/G&#945;<sub>11</sub> and G&#945;<sub>12</sub>/G&#945;<sub>13</sub> deficiency.</bold>
###xml 135 139 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tie2</italic>
###xml 140 143 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 145 147 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 470 471 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 478 480 447 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 507 509 472 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 516 518 477 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 611 612 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 619 621 572 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 629 631 578 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
Generation of mice with EC-specific Galphaq/Galpha11 and Galpha12/Galpha13 deficiency. (A) Gt(ROSA26)SorCre reporter mice carrying the tie2-CreERT2 transgene were treated with vehicle alone (untr.) or with tamoxifen (+Tam.) and then killed. The indicated organs were sectioned and stained for beta-galactosidase activity. Bars, 50 microm. Inserts represent 2x magnifications of the indicated areas. (B) Lysates from lung ECs prepared from tamoxifen-treated WT, EC-Galphaq/Galpha11-KO (q/11-KO), or EC-Galpha12/Galpha13-KO (12/13-KO) mice were analyzed by Western blotting with antibodies directed against Galphaq/Galpha11, Galpha13, alpha-tubulin, or beta-actin. Arrows indicate the position of the 43-kD marker protein. Shown are representative data from three independently performed experiments.
###end p 14
###begin title 15
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 28 30 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 60 62 60 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 64 66 64 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
Blockade of endothelial Gq/G11-mediated signaling, but not G12/G13-mediated signaling, inhibits local extravasation in response to various stimuli
###end title 15
###begin p 16
###xml 102 103 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 110 112 102 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 129 131 117 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 138 140 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 400 401 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 436 437 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 511 526 495 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, A and B</xref>
###xml 996 997 976 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1004 1006 980 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1048 1050 1020 1022 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1057 1059 1025 1027 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1149 1150 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1157 1159 1117 1119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1219 1220 1175 1176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1227 1229 1179 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1240 1242 1188 1190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1249 1251 1193 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1260 1268 1204 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 1647 1649 1587 1589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1656 1658 1592 1594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1713 1714 1645 1646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1721 1723 1649 1651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1782 1790 1710 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 1851 1852 1779 1780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1854 1856 1782 1784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1892 1894 1820 1822 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1896 1898 1824 1826 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1195 1199 <span type="species:ncbi:10090">mice</span>
###xml 1381 1385 <span type="species:ncbi:10090">mice</span>
###xml 1468 1473 <span type="species:ncbi:9606">human</span>
###xml 1662 1666 <span type="species:ncbi:10090">mice</span>
###xml 1676 1680 <span type="species:ncbi:10090">mice</span>
We then analyzed the effect of various vasoactive substances on the vascular permeability in EC-Galphaq/Galpha11-KO and EC-Galpha12/Galpha13-KO mice. In the absence of any intradermal injection, the vascular leakage of Evans blue given i.v. was negligible (unpublished data). Intradermal injection of lysophosphatidic acid (LPA), the protease-activated receptor 1 (PAR-1)-activating peptide SFLLRN-NH2, histamine, PAF, and leukotriene C4 each induced a dose-dependent increase in the leakage of Evans blue dye (Fig. 3, A and B; Fig. S2, available at ). In addition, intradermal injection of control buffer resulted in a small extravasation of Evans blue that was significantly smaller than the one seen in response to the vasoactive stimuli, suggesting that the manipulation resulted in the local release or production of some active mediators. Both basal vascular permeability and stimulus-induced increases in vascular permeability were severely reduced in mice with endothelial-specific Galphaq/Galpha11 deficiency but not in mice lacking Galpha12/Galpha13 in ECs. The small remaining response to the PAR1-activating peptide observed in EC-Galphaq/Galpha11-KO mice was not further reduced in mice lacking both Galphaq/Galpha11 and Galpha12/Galpha13 in ECs (Fig. 3 B). To test the regulation of the endothelial barrier in a more complex model of local anaphylaxis, we sensitized mice by intradermal injection of anti-DNP IgE antibodies and subsequently injected DNP-human serum albumin (HSA) systemically. In addition, in this IgE-mediated model of local anaphylaxis opening of the endothelial barrier was not significantly affected in EC-Galpha12/Galpha13-KO mice, whereas mice with endothelium-specific Galphaq/Galpha11 deficiency showed strongly reduced vascular permeability (Fig. 3 C). Thus, local regulation of vascular permeability requires Gq/G11-mediated signaling in ECs but not G12/G13.
###end p 16
###begin p 17
###xml 67 68 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 75 77 67 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 89 91 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 98 100 82 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 0 116 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Basal and stimulated endothelial permeability in EC-specific G&#945;<sub>q</sub>/G&#945;<sub>11</sub>- and G&#945;<sub>12</sub>/G&#945;<sub>13</sub>-deficient mice.</bold>
###xml 327 328 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
Basal and stimulated endothelial permeability in EC-specific Galphaq/Galpha11- and Galpha12/Galpha13-deficient mice. (A and B) Evans blue extravasation was determined in five to eight mice per genotype after intracutaneous injection of 20 microl of the indicated doses of PAF, histamine, LPA (A), or the PAR-1 peptide SFLLRN-NH2 (B). Shown are the amounts of Evans blue determined in skin explants as described in the Materials and methods. (C) At least five mice per genotype were sensitized by intracutaneous injection of anti-DNP IgE antibodies. 24 h later, DNP-HSA was injected i.v., and Evans blue extravasation was determined as described in the Materials and methods. Values are means +/- SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (compared with basal).
###end p 17
###begin title 18
###xml 77 78 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 85 87 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Systemic effects of histamine and PAF but not of LPS are blocked in EC-Galphaq/Galpha11-KO mice
###end title 18
###begin p 19
###xml 140 148 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 247 248 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 255 257 223 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 437 439 377 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 446 448 382 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 493 501 429 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 558 559 490 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 566 568 494 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 731 732 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 739 741 659 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 759 761 675 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 768 770 680 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 862 863 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 863 868 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#969;</sup>
###xml 875 876 783 784 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 900 901 808 809 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 908 923 816 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, B and C</xref>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
i.v. injection of histamine induced a rapid and transient drop in the systolic blood pressure to levels of approximately50 mmHg in WT mice (Fig. 4 A). Normal values were restored approximately90 min after the application of histamine. In EC-Galphaq/Galpha11-KO mice, the same dose decreased blood pressure for only approximately20 min with maximal hypotensive values of approximately90 mmHg, whereas mice with endothelium-specific Galpha12/Galpha13 deficiency responded comparable to WT mice (Fig. 4 A). The strongly reduced hypotensive response of EC-Galphaq/Galpha11-KO mice to histamine was not caused by a general defect in the regulation of the vascular tone, as is indicated by the indistinguishable response of WT, EC-Galphaq/Galpha11-KO, and EC-Galpha12/Galpha13-KO mice to the NO-donor sodium nitroprusside as well as to the NO synthase (NOS) inhibitor Nomega-nitro-l-arginine methyl ester (l-NAME; Fig. 4, B and C).
###end p 19
###begin p 20
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 24 26 24 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 36 38 36 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Role of endothelial G<sub>q</sub>/G<sub>11</sub> and G<sub>12</sub>/G<sub>13</sub> in the systemic effects of histamine, PAF, and LPS.</bold>
###xml 508 509 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1231 1232 1213 1214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1239 1241 1217 1219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
###xml 1245 1249 <span type="species:ncbi:10090">mice</span>
Role of endothelial Gq/G11 and G12/G13 in the systemic effects of histamine, PAF, and LPS. (A) Arterial blood pressure was monitored telemetrically in mice before and after i.v. injection of carrier solution (squares) or 10 mg/kg histamine (circles). Shown are mean values of five to seven animals per genotype +/-SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (compared with WT). The arrow indicates the time point of injection. (B) Arterial blood pressure was monitored telemetrically in anesthesized mice (n >/= 5 per genotype) before and after i.v. injection of 50 mg/kg l-NAME. Shown is the maximal blood pressure change, in millimeters of mercury, after injection of the NOS inhibitor. Values are the means +/- S.D. (C) Arterial blood pressure was monitored telemetrically in mice before and after i.v. injection of 1 mg/kg sodium nitroprusside. Shown are mean values of 5-8 animals per genotype +/- S.D. (D and E) Five to six mice per genotype were injected i.v. with 1.9 microg/g PAF, and body temperature (D) and survival (E) were monitored over 120 min. Numbers below the time points of the temperature plot indicate the number of animals still alive at the indicated times (mean values +/- SD). (F) Three WT and EC-Galphaq/Galpha11-KO mice were injected i.p. with 80 microg/g LPS, and the blood pressure was monitored telemetrically for the indicated time period. Shown are the mean values +/- SD.
###end p 20
###begin p 21
###xml 56 57 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 64 66 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 77 79 65 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 86 88 70 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 199 201 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 202 204 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 257 265 241 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 312 314 292 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 321 323 297 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 347 355 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 395 396 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 403 405 371 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 566 581 534 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, D and E</xref>
###xml 608 610 572 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 693 694 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 701 703 657 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 930 932 882 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 939 941 887 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 968 969 912 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 976 978 916 918 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 988 994 928 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 1038 1039 974 975 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1046 1048 978 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">Mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
We then tested the effect of endothelium-specific Galphaq/Galpha11 and Galpha12/Galpha13 deficiency on the systemic response to PAF, which is thought to be a critical mediator of anaphylactic shock (32-34). i.v. injection of PAF induced severe hypothermia (Fig. 4 D) and resulted in the death of WT and EC-Galpha12/Galpha13-KO mice within 20 min (Fig. 4 E). However, mice with endothelial Galphaq/Galpha11 deficiency were protected from PAF-induced shock, and all of the animals assessed survived the injection of PAF with only a transient drop in body temperature (Fig. 4, D and E). Mice lacking only Galpha11 demonstrated an intermediate phenotype with more severe hypothermia than EC-Galphaq/Galpha11-KO mice and a survival rate of only 25% (two of eight tested animals; unpublished data). Interestingly, the intraperitoneal injection of the endotoxin LPS induced a severe hypotension and eventual lethality in WT and EC-Galpha12/Galpha13-KO as well as in EC-Galphaq/Galpha11-KO mice (Fig. 4 and not depicted). Thus, endothelial Galphaq/Galpha11 deficiency does not protect from endotoxic shock.
###end p 21
###begin title 22
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
Anaphylactic shock depends on endothelial Gq/G11
###end title 22
###begin p 23
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 233 235 233 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 241 243 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 245 247 245 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 323 324 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 331 333 323 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 350 352 338 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 359 361 343 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 450 458 434 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 476 478 456 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 485 487 461 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 870 878 834 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 944 945 904 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 952 954 908 910 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1054 1055 1006 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1062 1064 1010 1012 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1123 1138 1071 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, A and B</xref>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
###xml 1068 1072 <span type="species:ncbi:10090">mice</span>
To further evaluate the role of endothelial G protein-mediated signaling pathways under pathophysiologically more relevant conditions, we set up models for passive and active systemic anaphylaxis. To test the role of endothelial Gq/G11 and G12/G13 in passive systemic IgE-dependent anaphylaxis, we injected WT and EC-Galphaq/Galpha11-KO and EC-Galpha12/Galpha13-KO mice i.v. with anti-DNP IgE and challenged them 24 h later with DNP-HSA. As shown in Fig. 5 A, WT and EC-Galpha12/Galpha13-KO mice responded with a rapid drop in systolic blood pressure down to values of approximately35 mmHg. After a few minutes, the blood pressure started to slowly rise but remained hypotensive for more than 90 min. Both lines also showed a strong increase in their hematocrit when determined 10 min after application of the allergen as an indicator of severe extravasation of plasma (Fig. 5 B). Under the same conditions, mice with endothelial lack of Galphaq/Galpha11 showed only a small and very transient reduction in blood pressure, and the hematocrit of EC-Galphaq/Galpha11-KO mice remained unchanged after allergen administration (Fig. 5, A and B).
###end p 23
###begin p 24
###xml 61 62 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 69 71 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 83 85 71 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 92 94 76 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 0 110 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Passive and active anaphylaxis in endothelium-specific G&#945;<sub>q</sub>/G&#945;<sub>11</sub>- and G&#945;<sub>12</sub>/G&#945;<sub>13</sub>-deficient mice.</bold>
###xml 950 952 928 930 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 959 961 933 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 980 981 950 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 988 990 954 956 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1026 1027 988 989 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1034 1036 992 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">Mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
Passive and active anaphylaxis in endothelium-specific Galphaq/Galpha11- and Galpha12/Galpha13-deficient mice. (A and B) Mice were either sensitized with anti-DNP IgE antibodies (A, circles; B, black bars) or received buffer (A, squares; B, white bars). 24 h later, animals were challenged by i.v. injection of DNP-HSA as described in Materials and methods. Shown is the arterial blood pressure monitored telemetrically before and after administration of DNP-HSA (A) as well as the change in hematocrit 10 min after administration of DNP-HSA (B). The data represent mean values of five to six animals per group +/-SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (compared with WT). The arrow in A indicates the time point of DNP-HSA injection. (C and D) Body temperature (C) and survival (D) of mice sensitized with BSA and challenged 14 d later with BSA (circles) or buffer (squares). Experiments were performed with a total of five WT, four EC-Galpha12/Galpha13-KO, five EC-Galphaq/Galpha11-KO (immunized), and three EC-Galphaq/Galpha11-KO (nonimmunized) mice. Numbers below the time points of the temperature plot indicate the number of mice still alive at the indicated times. Shown are mean values +/- SD.
###end p 24
###begin p 25
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 251 253 247 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 260 262 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 291 299 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 D</xref>
###xml 348 349 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 356 358 340 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 452 453 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 496 511 468 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, C and D</xref>
###xml 538 540 506 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">Mice</span>
We then actively sensitized mice with BSA together with adjuvant. 2 wk later, mice were challenged with an i.v. injection of the same allergen. Within minutes after this challenge, all mice developed severe hypothermia (Fig. 5 C), and WT and EC-Galpha12/Galpha13-KO mice died within 20 min (Fig. 5 D). However, mice with endothelium-specific Galphaq/Galpha11 deficiency recovered from hypothermia after approximately1 h, and all of the tested animals (n = 5) survived the anaphylactic challenge (Fig. 5, C and D). Mice lacking only Galpha11 exhibited an intermediate phenotype in the active systemic anaphylaxis model showing a survival rate of 20% (2 of 10 animals; unpublished data).
###end p 25
###begin title 26
DISCUSSION
###end title 26
###begin p 27
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 478 479 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 481 483 481 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 755 756 751 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 763 765 755 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 816 817 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 824 826 808 810 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 858 860 838 840 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 867 869 843 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 995 996 971 972 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 998 1000 974 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1099 1100 1075 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1102 1104 1078 1080 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1219 1220 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1222 1224 1198 1200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1402 1403 1374 1375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1410 1412 1378 1380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
The pathological processes induced by mediators of anaphylaxis involve diverse organs such as the bronchial and immune systems, blood vessels, or the heart and require complex cell-cell and mediator-mediator interactions which involve various signaling pathways (5, 35, 36). In this study, we addressed the role of defined endothelial G protein-mediated signaling pathways in the pathomechanism of systemic anaphylaxis. We report here that the endothelium-specific ablation of Gq/G11 prevents the loss of the endothelial barrier function induced by various inflammatory mediators as well as by local anaphylaxis. The systemic effects of anaphylactic mediators like histamine and PAF as well as of IgE-mediated passive anaphylaxis were blunted in EC-Galphaq/Galpha11-KO mice, and mice with endothelium-specific Galphaq/Galpha11 deficiency, but not with Galpha12/Galpha13 deficiency, were protected against the fatal consequences of active systemic anaphylaxis. Thus, the blockade of endothelial Gq/G11 signaling is sufficient to protect against fatal anaphylactic shock, indicating that endothelial Gq/G11-mediated signaling is critically involved in local and systemic anaphylactic reactions. In contrast, endothelial Gq/G11 does not appear to play a role in septic shock as the degree of hypotension and the lethality after systemic administration of LPS was indistinguishable between WT and EC-Galphaq/Galpha11-KO mice.
###end p 27
###begin p 28
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 41 43 41 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 45 47 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 235 237 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 238 240 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 396 397 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 404 406 392 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 417 419 401 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 426 428 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 465 466 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 468 470 448 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 476 478 456 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 480 482 460 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 542 543 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 550 552 522 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 562 564 530 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 571 573 535 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 721 722 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 729 731 685 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 741 743 693 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 750 752 698 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 921 922 865 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 929 931 869 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1026 1027 966 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1029 1031 969 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1037 1039 977 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1041 1043 981 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1161 1162 1101 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1164 1166 1104 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1328 1330 1264 1266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1378 1380 1314 1316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1408 1410 1344 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 1412 1414 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 1433 1435 1365 1367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1442 1444 1370 1372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1549 1551 1477 1479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1553 1555 1481 1483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1687 1689 1615 1617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
###xml 1309 1313 <span type="species:ncbi:10090">mice</span>
###xml 1448 1452 <span type="species:ncbi:10090">mice</span>
The analysis of the role of Gq/G11- and G12/G13-mediated signaling pathways in the adult endothelium under in vivo conditions has been hampered by the fact that mice lacking the alpha subunits of these G proteins are embryonic lethal (37-39). By crossing a newly generated inducible and endothelium-specific Cre transgenic mouse line with conditional and null alleles of the genes encoding Galphaq/Galpha11 and Galpha12/Galpha13, we were able to study the role of Gq/G11 and G12/G13 in the endothelium of adult animals in which lack of Galphaq/Galpha11 or Galpha12/Galpha13 did not lead to any obvious defects. There was also no acute or delayed change in the systemic blood pressure after induction of endothelial Galphaq/Galpha11 or Galpha12/Galpha13 deficiency (unpublished data). At the same time, the short and transient drop in blood pressure induced by i.v. injection of histamine was strongly reduced in EC-Galphaq/Galpha11-KO mice, indicating that pharmacological responses were affected. Thus, although endothelial Gq/G11 and G12/G13 are obviously not critically involved in the regulation of vascular functions under basal physiological conditions, Gq/G11-mediated signaling plays a crucial role in the regulation of endothelial functions under inflammatory and anaphylactic conditions. Studies in mice lacking Galpha13 have indicated a critical role of endothelial G13 in embryonic angiogenesis (38, 40). Female EC-Galpha12/Galpha13-KO mice are fertile, and we have not observed any defects in wound healing suggesting that endothelial G12/G13 are not required for adult angiogenesis in the female reproductive system or during wound healing. However, the potential role of G13 in tumor angiogenesis remains to be evaluated.
###end p 28
###begin p 29
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 592 594 592 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 755 756 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 758 760 758 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 766 768 766 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 770 772 770 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 826 827 822 823 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 834 836 826 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 848 850 836 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 857 859 841 843 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 967 968 951 952 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 970 972 954 956 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1040 1041 1020 1021 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1105 1106 1081 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1113 1115 1085 1087 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1149 1151 1121 1123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1153 1155 1125 1127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1276 1278 1248 1250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1280 1282 1252 1254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1481 1483 1449 1451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1490 1492 1454 1456 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1616 1617 1576 1577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1624 1626 1580 1582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1684 1685 1640 1641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1687 1689 1643 1645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1705 1707 1661 1663 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1709 1711 1665 1667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 1820 1822 1776 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 1832 1833 1788 1789 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 1835 1837 1791 1793 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 1871 1873 1827 1829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1875 1877 1831 1833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
The stimulation of endothelial permeability by inflammatory and anaphylactic mediators like thrombin, bradykinin, histamine, PAF, etc. requires the retraction of ECs as a result of increased actomyosin-mediated contraction as well as the disruption of cell-cell contacts (41, 42). Endothelial contraction is regulated by the phosphorylation state of the MLC which in its phosphorylated form allows myosin to interact with actin and to generate contractile forces (43, 44). Analogous to the situation in smooth muscle cells (45-47), the dual regulation of MLC phosphorylation in ECs via the Ca2+-dependent MLC kinase activation and the Rho/Rho kinase-mediated myosin phosphatase inhibition is believed to be initiated by the dual coupling of receptors to Gq/G11 and G12/G13, respectively (44). Our in vitro studies using Galphaq/Galpha11- and Galpha12/Galpha13-deficient pulmonary ECs indicate that thrombin-induced MLC phosphorylation is abrogated in the absence of Gq/G11, a defect which can be rescued by transfection of cells with Galphaq, whereas RhoA activation by thrombin was not affected in Galphaq/Galpha11-deficient ECs. In cells lacking G12/G13, MLC phosphorylation in response to thrombin was only reduced and RhoA activation was blocked. This indicates that the G12/G13-RhoA-mediated signaling pathway plays only a minor role in thrombin-induced MLC phosphorylation in primary pulmonary ECs. This is consistent with our in vivo data, which show that endothelial Galpha12/Galpha13 deficiency has no effect on vascular leakage induced by thrombin, PAF, histamine, or anaphylactic reactions, whereas Galphaq/Galpha11 deficiency blocked these effects. A predominant role of Gq/G11 compared with G12/G13 was recently also demonstrated for thrombin-induced increase in endothelial permeability analyzed in vitro (48). Thus, Gq/G11-mediated signaling, rather than G12/G13, is critically involved in the regulation of endothelial barrier function by inflammatory mediators acting via GPCRs.
###end p 29
###begin p 30
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">52</xref>
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 580 582 580 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 595 597 595 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 599 601 599 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 649 651 649 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">53</xref>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
The role of NO in systemic anaphylaxis has been controversial (49, 50). Recently, it was shown that the systemic inhibition of NOSs prevented mortality in various models of anaphylaxis in mice (51). This effect could also be seen in mice lacking the endothelial NOS (eNOS) but not the inducible NOS (iNOS). Although eNOS is expressed in ECs, it can also be found in various other tissues, and it has been suggested that it is the NO production in non-ECs which is involved in anaphylaxis (52). Our data indicate that the stimulation of NO formation in isolated ECs depends on Gq/G11 but not on G12/G13. In addition, endothelium-specific lack of Gq/G11 results in a strong reduction in histamine-induced hypotension and various anaphylactic reactions very similar to the effects seen in mice lacking eNOS (51, 53). Thus, our data are consistent with a primary role of endothelial NOS in systemic anaphylaxis.
###end p 30
###begin p 31
###xml 96 97 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 104 106 96 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 116 118 104 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 125 127 109 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 231 232 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 239 241 215 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 311 313 283 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 320 322 288 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 379 380 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 387 389 347 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 587 588 547 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 590 592 550 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 699 700 659 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 702 704 662 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
Using conditional mutagenesis, we have generated mice with inducible endothelium-specific Galphaq/Galpha11 or Galpha12/Galpha13 deficiency. When challenged with anaphylactic mediators or subjected to systemic anaphylaxis, EC-Galphaq/Galpha11-KO mice were protected, whereas mice with endothelium-specific Galpha12/Galpha13 deficiency responded like WT animals. Endothelial Galphaq/Galpha11 deficiency blocked MLC phosphorylation and NO formation as well as increases in vascular permeability induced by various inflammatory and anaphylactic mediators. This study identifies endothelial Gq/G11-mediated signaling as a critical process in the pathophysiology of systemic anaphylaxis. Because lack of Gq/G11-mediated signaling does not affect basal physiological regulation of endothelial function, it may be an interesting target to treat systemic anaphylaxis.
###end p 31
###begin title 32
MATERIALS AND METHODS
###end title 32
###begin title 33

###end title 33
###begin title 34
Chemicals and antibodies.
###end title 34
###begin p 35
###xml 69 73 65 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q/11</sub>
###xml 89 91 81 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 273 274 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
For Western blotting, the following antibodies were used: anti-Galphaq/11 and anti-Galpha13 (Santa Cruz Biotechnology, Inc.), anti-alpha-tubulin and anti-MLC (Sigma-Aldrich), and anti-pMLC (Cell Signaling Technology). Histamine, thrombin, PAF, LPA, PAR-1 peptide (SFLLRN-NH2), Evans blue, anti-DNP-IgE, DNP-HSA, and BSA were obtained from Sigma-Aldrich. Ionomycin was obtained from Invitrogen.
###end p 35
###begin title 36
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
Genetic mouse models.
###end title 36
###begin p 37
###xml 206 207 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 209 213 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnaq</italic>
###xml 225 227 217 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 229 234 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna13</italic>
###xml 284 286 272 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 288 293 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna11</italic>
###xml 305 307 289 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 309 314 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna12</italic>
###xml 348 350 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 352 354 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 356 358 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 360 362 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
All procedures of animal care and use in this study were approved by the local animal ethics committee (Regierungsprasidium Karlsruhe, Germany). The generation of floxed alleles of the genes encoding Galphaq (Gnaq) and Galpha13 (Gna13) and of null alleles of the genes encoding Galpha11 (Gna11) and Galpha12 (Gna12) have been described previously (29, 30, 37, 39).
###end p 37
###begin p 38
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 98 100 98 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 282 286 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tie2</italic>
###xml 357 359 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">54</xref>
###xml 360 362 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">56</xref>
###xml 694 698 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tie2</italic>
###xml 699 702 696 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 704 706 701 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 143 149 <span type="species:ncbi:9913">bovine</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
To generate an inducible EC-specific Cre transgenic mouse line, a cassette consisting of the CreERT2 followed by a polyadenylation signal from bovine growth hormone and a module containing the beta-lactamase gene flanked by frt sites was introduced into the coding ATG of the mouse tie2 gene carried by a BAC using ET recombination as previously described (54-56). Correct recombinants were verified by Southern blotting. After FLPe-mediated recombination, the recombined BAC was injected into male pronuclei derived from fertilized FvB/N oozytes. Transgenic offspring were analyzed for BAC insertion by genomic PCR amplification. To verify inducibility and activity of the Cre fusion protein, tie2-CreERT2 mice were mated with animals of the Cre reporter transgenic line Gt(ROSA)26Sortm1sor (ROSA26-LacZ). Cotransgenic progeny from these matings were treated i.p. with 5 x 1 mg/d tamoxifen or vehicle alone and were killed 14 d after induction. For histological analysis of beta-galactosidase activity, staining was performed on 10-12-microm cryosections followed by eosin counterstaining.
###end p 38
###begin title 39
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Isolation of mouse primary pulmonary ECs.
###end title 39
###begin p 40
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">57</xref>
###xml 617 618 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 655 656 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 721 722 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 730 732 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">58</xref>
###xml 734 736 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">59</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse lung ECs were isolated as described previously (57). Lungs were minced and digested in 50 U/ml dispase for 1 h at 37degreesC with shaking (350 rpm). After filtration, the cells were washed in PBS containing 0.5% BSA. Cells were incubated with anti-CD144 antibody-coated (BD) magnetic beads (Invitrogen) for 1 h at room temperature, washed, and isolated with a magnet (Invitrogen). Cells were grown in DMEM/F12 (Invitrogen) supplemented with 10% FBS, penicillin/streptomycin, and EC growth supplement with heparin (PromoCell) on fibronectin-coated wells. To induce Cre-mediated recombination or to express Galphaq, the cells were infected with 5 x 107 PFU of Adeno-Cre-GFP virus (Vector Laboratories) or Adeno-Galphaq virus (58, 59) 72 h before the experiments.
###end p 40
###begin title 41
RhoA activation assay.
###end title 41
###begin p 42
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
RhoA activation in primary ECs was detected by a luminescence-based G-LISA RhoA activation assay kit (tebu-bio) according to the manufacturer's instructions. Briefly, mouse primary lung ECs were grown on 12-well plates and stimulated with 1 U/ml thrombin for 1 min, washed with 1.5 ml of ice-cold PBS, and lysed in 150 microl of lysis buffer on ice. Protein concentrations were measured and equalized with lysis buffer if necessary.
###end p 42
###begin title 43
Detection of MLC phosphorylation.
###end title 43
###begin p 44
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
For detection of MLC phosphorylation, mouse primary ECs were cultured on 24-well plates. The cells were stimulated with 1 U/ml thrombin for the indicated time periods and lysed in 2x Laemmli buffer, incubated for 10 min at 100degreesC, and then loaded on 12% SDS PAGE gels. MLC phosphorylation was detected by Western blotting using an anti-pMLC antibody (1:1,000).
###end p 44
###begin title 45
Determination of NO production.
###end title 45
###begin p 46
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">60</xref>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnaq</italic>
###xml 80 89 80 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna11</italic>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna12</italic>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gna13</italic>
###xml 117 126 117 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 460 461 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
NO formation was determined as previously described (60). Lung ECs from WT, Gnaqflox/flox;Gna11-/-, or Gna12-/-;Gna13flox/flox mice were cultured and treated with Cre transducing adenovirus as described. Cells were then suspended by treatment with accutase (PAA Laboratories) and washed in Hepes-buffered Tyrode solution containing 0.1 mM of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine and 100 U/ml of superoxide dismutase. Approximately 5 x 104 cells were added to RFL6 fibroblasts cultured in 24-well plates and incubated (37degreesC) for 5 min in the absence or presence of the indicated stimuli. Thereafter, the incubation was stopped by the addition of trichloroacetic acid (6%), and the concentration of cyclic GMP was determined by a radioimmunoassay (GE Healthcare).
###end p 46
###begin title 47
Vascular permeability assay.
###end title 47
###begin p 48
###xml 424 425 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 82 86 <span type="species:ncbi:10090">Mice</span>
###xml 372 376 <span type="species:ncbi:10090">Mice</span>
We determined agonist-induced vascular permeability changes using Evans blue dye. Mice were anaesthetized with 50 mg/kg pentobarbital sodium and injected i.v. with 0.04 microg/g Evans Blue in saline. After 1 min, different doses of agonists (histamine, PAF, PAR-1 peptide, and LPA) in 20 microl of PBS were injected into the shaved back skin. PBS was injected as control. Mice were killed after 10 min, and approximately1 cm2 of skin containing the site of injection was removed. The skin punches were incubated in 500 microl of formamide at 55degreesC for 48 h, and the Evans blue content was determined by absorption at 595 nm.
###end p 48
###begin title 49
Passive cutaneous anaphylaxis.
###end title 49
###begin p 50
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">Mice</span>
30 ng of anti-DNP IgE in 20 microl of sterile 0.9% NaCl was injected into the dorsal skin of the right ear. The left ear of mice received an equal volume of saline and served as control. After 24 h, we challenged the passively immunized mice by an i.v. injection of 0.5 mg of DNP-HSA together with 0.08 microg/g Evans blue in saline. Mice were killed 30 min after the challenge by cervical dislocation, and ear biopsies were collected. Evans blue was extracted in 400 microl of formamide at 55degreesC for 24 h and quantified by measuring light absorption at 595 nm.
###end p 50
###begin title 51
Telemetric blood pressure and body temperature measurements.
###end title 51
###begin p 52
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
We used a radiotelemetry system (PA-C10; Data Sciences International) to monitor blood pressure in conscious unrestrained mice, as described previously (46). Pressure sensing catheters were implanted into the left carotid artery, and the transducer unit was inserted into a subcutaneous pouch along the right flank. After a recovery period of at least 1 wk, arterial pressure recordings were collected, stored, and analyzed with Dataquest A.R.T. software (version 4.0; Data Sciences International). We collected data for basal blood pressure measurements with a 10-s scheduled sampling every 5 min and used the 24-h mean values for analysis. For analyzing the acute effects of agonists, we collected data continuously in 5-s intervals for different time periods as indicated in the figures. The body temperature was measured with a temperature control module (TKM-0902; Fohr Medical Instruments GmbH).
###end p 52
###begin title 53
Passive systemic anaphylaxis.
###end title 53
###begin p 54
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
To induce passive systemic anaphylaxis, we injected mice i.v. with 20 microg of anti-DNP IgE. After 24 h, we challenged these passively immunized mice by an i.v. injection of 1 mg DNP-HSA. Control mice were injected with saline and challenged as described for immunized mice. For determining hematocrit, blood samples were collected before and 10 min after the challenge. Blood pressure measurements were done using the telemetric system.
###end p 54
###begin title 55
Active systemic anaphylaxis.
###end title 55
###begin p 56
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
For inducing active systemic anaphylaxis, we first immunized mice with i.p. injection of 1 mg BSA and 300 ng pertussis toxin as adjuvant in pyrogen-free 0.9% NaCl. After 14 d, mice were challenged with i.v. injection of 2 mg BSA. We monitored the body temperature and survival of the mice for 120 min after the challenge.
###end p 56
###begin title 57
Online supplemental material.
###end title 57
###begin p 58
###xml 43 44 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 51 53 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 123 124 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 131 133 115 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 184 185 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 271 272 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sub>
###xml 279 281 255 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows that the expression of Galphaq/Galpha11 did not differ between various non-ECs prepared from WT and EC-Galphaq/Galpha11-KO mice. Fig. S2 shows the effect of leukotriene C4 on the extravasation of Evan's blue in WT and the absence of this effect in EC-Galphaq/Galpha11-KO. Online supplemental material is available at .
###end p 58
###begin title 59
Supplementary Material
###end title 59
###begin title 60
[Supplemental Material Index]
###end title 60
###begin p 61
We thank Manuela Ritzal, Melanie Bernhard, and Isabel Winter for expert technical assistance and Rose LeFaucheur for excellent secretarial help.
###end p 61
###begin p 62
T. Wieland was supported by the German Research Foundation (TR/SFB 23), and N. Wettschureck and S. Offermanns were supported by the German Research Foundation (SFB 405).
###end p 62
###begin p 63
The authors have no conflicting financial interests.
###end p 63
###begin article-title 64
Epidemiology of anaphylaxis.
###end article-title 64
###begin article-title 65
Anaphylaxis: a review of causes and mechanisms.
###end article-title 65
###begin article-title 66
Anaphylaxis in the United States: an investigation into its epidemiology.
###end article-title 66
###begin article-title 67
Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.
###end article-title 67
###begin article-title 68
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Anaphylaxis: lessons from mouse models.
###end article-title 68
###begin article-title 69
Mast cells and basophils.
###end article-title 69
###begin article-title 70
Mediators of anaphylaxis.
###end article-title 70
###begin article-title 71
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta.
###end article-title 71
###begin article-title 72
International Union of Pharmacology. XIII. Classification of histamine receptors.
###end article-title 72
###begin article-title 73
Role of platelet-activating factor in cardiovascular pathophysiology.
###end article-title 73
###begin article-title 74
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
###end article-title 74
###begin article-title 75
###xml 100 106 <span type="species:ncbi:9913">bovine</span>
Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells.
###end article-title 75
###begin article-title 76
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the leukotriene B4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis.
###end article-title 76
###begin article-title 77
Platelet-activating factor and related lipid mediators.
###end article-title 77
###begin article-title 78
The mast cell and the cysteinyl leukotrienes.
###end article-title 78
###begin article-title 79
International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.
###end article-title 79
###begin article-title 80
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human heart as a shock organ in anaphylaxis.
###end article-title 80
###begin article-title 81
Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.
###end article-title 81
###begin article-title 82
Platelet function in anaphylaxis.
###end article-title 82
###begin article-title 83
Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals.
###end article-title 83
###begin article-title 84
Platelet-activating factor receptor.
###end article-title 84
###begin article-title 85
###xml 71 76 <span type="species:ncbi:9606">human</span>
Platelet-activating factor activates two distinct effector pathways in human eosinophils.
###end article-title 85
###begin article-title 86
Leukotriene D4 activates distinct G-proteins in intestinal epithelial cells to regulate stress fibre formation and to generate intracellular Ca2+ mobilisation and ERK1/2 activation.
###end article-title 86
###begin article-title 87
Histamine H1-receptors in HL-60 monocytes are coupled to Gi-proteins and pertussis toxin-insensitive G-proteins and mediate activation of Ca2+ influx without concomitant Ca2+ mobilization from intracellular stores.
###end article-title 87
###begin article-title 88
Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers.
###end article-title 88
###begin article-title 89
Heterotrimeric G-proteins: a short history.
###end article-title 89
###begin article-title 90
Heterotrimeric G protein activation by G-protein-coupled receptors.
###end article-title 90
###begin article-title 91
Mammalian G proteins and their cell type specific functions.
###end article-title 91
###begin article-title 92
G13 is an essential mediator of platelet activation in hemostasis and thrombosis.
###end article-title 92
###begin article-title 93
Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.
###end article-title 93
###begin article-title 94
Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
###end article-title 94
###begin article-title 95
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021.
###end article-title 95
###begin article-title 96
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.
###end article-title 96
###begin article-title 97
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
###end article-title 97
###begin article-title 98
The pathophysiology of shock in anaphylaxis.
###end article-title 98
###begin article-title 99
Immunology and Allergy Clinics of North America: Anaphylaxis.
###end article-title 99
###begin article-title 100
Effector cells of anaphylaxis: mast cells and basophils.
###end article-title 100
###begin article-title 101
Anaphylaxis.
###end article-title 101
###begin article-title 102
Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways.
###end article-title 102
###begin article-title 103
Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency.
###end article-title 103
###begin article-title 104
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice.
###end article-title 104
###begin article-title 105
Essential role for Galpha13 in endothelial cells during embryonic development.
###end article-title 105
###begin article-title 106
Regulation of endothelial barrier responses and permeability.
###end article-title 106
###begin article-title 107
Endothelial Biomedicine.
###end article-title 107
###begin article-title 108
Signaling mechanisms regulating endothelial permeability.
###end article-title 108
###begin article-title 109
Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation.
###end article-title 109
###begin article-title 110
Transport across the endothelium: regulation of endothelial permeability.
###end article-title 110
###begin article-title 111
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase.
###end article-title 111
###begin article-title 112
G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension.
###end article-title 112
###begin article-title 113
Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction.
###end article-title 113
###begin article-title 114
Protein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha 12/13 and Galpha 11/q.
###end article-title 114
###begin article-title 115
An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock.
###end article-title 115
###begin article-title 116
###xml 112 119 <span type="species:ncbi:9986">rabbits</span>
Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits.
###end article-title 116
###begin article-title 117
Anaphylactic shock depends on PI3K and eNOS-derived NO.
###end article-title 117
###begin article-title 118
What's in a name? eNOS and anaphylactic shock.
###end article-title 118
###begin article-title 119
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Hypertension in mice lacking the gene for endothelial nitric oxide synthase.
###end article-title 119
###begin article-title 120
A CamKIIalpha iCre BAC allows brain-specific gene inactivation.
###end article-title 120
###begin article-title 121
Rapid modification of bacterial artificial chromosomes by ET-recombination.
###end article-title 121
###begin article-title 122
###xml 55 71 <span type="species:ncbi:562">Escherichia coli</span>
A new logic for DNA engineering using recombination in Escherichia coli.
###end article-title 122
###begin article-title 123
Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells.
###end article-title 123
###begin article-title 124
A simplified system for generating recombinant adenoviruses.
###end article-title 124
###begin article-title 125
Regulation of cardiac cAMP synthesis and contractility by nucleoside diphosphate kinase B/G protein beta gamma dimer complexes.
###end article-title 125
###begin article-title 126
Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin.
###end article-title 126
###begin p 127
###xml 201 202 201 202 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 222 223 218 219 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 180 185 <span type="species:ncbi:9606">human</span>
Abbreviations used: BAC, bacterial artificial chromosome; cGMP, cyclic guanosine monophosphate; EC, endothelial cell; eNOS, endothelial NOS; GPCR, G protein-coupled receptor; HSA, human serum albumin; l-NAME, Nomega-nitro-l-arginine methylester; LPA, lysophosphatidic acid; MLC, myosin light chain; NO, nitric oxide; NOS, NO synthase; PAF, platelet-activating factor.
###end p 127

